Norrsken Mind adopts a shared leadership model and appoints Marcus Stråth as Co-Managing Director alongside Emma Christersson, current Managing Director. Marcus joins Norrsken Mind from the strategic communications advisory firm Brunswick Group. He has previously supported Norrsken Mind as Head of Communication.

As co-Managing Directors, Emma and Marcus are responsible for realizing Norrrsken Mind’s mission to improve the understanding of psychedelic-assisted treatments by catalyzing research across Europe. 

“I’m excited to lead Norrsken Mind with Marcus as my partner. We have a long history of collaboration, and complement each other well with different backgrounds and skill sets. A dual leadership is an optimal structure for an organization with our focus and size. It will make us even more effective in our work to support progress in the psychedelic field,” says Emma Christersson, Co-Managing Director of Norrsken Mind. 

“I am grateful and thrilled to work alongside Emma in leading Norrsken Mind forward. We bring researchers and philanthropists together in our common goal to improve the understanding of psychedelics and their therapeutic potential. Supporting research is the single most important aspect to have a sustainable and long-term impact for mental healthcare,” says Marcus Stråth, Co-Managing Director of Norrsken Mind. 

About Marcus Stråth 

Marcus Stråth is co-Managing Director of Norrsken Mind. Marcus previously worked with strategic communication at Brunswick Group and has been Head of Communication of Norrsken Mind since June 2023. He has been active in the psychedelic non-profit sector since 2018 and has advised Norrsken Mind, and formerly Osmond Foundation, since its inception. Marcus was previously a board member of the Swedish Network for Psychedelic Science and deputy board member of Osmond Labs. Marcus holds a bachelor’s degree in Business Administration with a minor in journalism.

About Emma Christersson 

Emma Christersson is co-Managing Director of Norrsken Mind. Emma has been active in the psychedelic non-profit sector since 2017 and was previously board member and interim chair of Osmond Foundation, board member and strategist for Osmond Labs, and deputy chair of the Swedish Network for Psychedelic Science. Emma holds a bachelor's degree in cognitive neuroscience and has a specific interest in neuropsychology and consciousness.

About Norrsken Mind 

Norrsken Mind is a foundation focused on supporting research on psychedelic substances and their potential to treat mental health disorders through fundraising and grant opportunities. Our goal is to catalyse research across Europe to improve the understanding of psychedelic-assisted treatments, as well as to inform and engage with mental health stakeholders through education and training efforts. Norrsken Mind is a continuation of Osmond Foundation, which funded the first Swedish modern clinical trial using psilocybin-assisted therapy to treat depression at Karolinska Institutet.

‍